{"podcast":{"title":"Data in Biotech","slug":"data-in-biotech-6628050","podcast_index_feed_id":6628050,"rss_url":"https://feed.pod.co/data-in-biotech","website_url":"https://www.corrdyn.com/","image_url":"https://images.pod.co/0up9NpIiXg38dg9ONujjEbhtOuwAOa32iObZVZ8ridQ/resize:fill:1500:1500/plain/artwork/9bd88ed6-6c74-4788-924c-56be77376f84/data-in-biotech.jpg","author":"CorrDyn","episode_count":77,"summary":"Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter strategic decisions - at www.corrdyn.com","last_synced_at":"2026-09-03T06:17:20.333193+00:00","page_url":"https://stenobird.com/podcast/data-in-biotech-6628050"},"episode":{"title":"Success-Driven Drug Discovery with OpenBench CEO James Yoder","slug":"success-driven-drug-discovery-with-openbench-ceo-james-yoder","published_at":"2026-02-11T18:00:28+00:00","page_url":"https://stenobird.com/podcast/data-in-biotech-6628050/success-driven-drug-discovery-with-openbench-ceo-james-yoder","show_page_url":"https://stenobird.com/podcast/data-in-biotech-6628050","url":"https://www.corrdyn.com/","audio_url":"https://downloads.pod.co/5fac40cd-043b-485f-838d-c63fa01ae1b2/34e29044-9bef-4d6c-9298-cc053158c9d4.mp3","summary":"In this episode of Data in Biotech , host Ross Katz sits down with James Yoder, Founder and CEO of OpenBench, to unpack a radical new approach to early-stage drug discovery. James shares how OpenBench's \"success-driven\" model shifts risk away from biotech partners by only charging for validated hits. They dive deep into computational screening, molecular modeling, and the company's evolving tech stack that's making hit discovery smarter and more accessible. Discover how data, AI, and strategic collaboration are redefining biotech R&D. What you'll learn in this episode: >> Why OpenBench moved away from SaaS to a success-based service model >> How their computational platform predicts binding affinity and screens trillions of compounds >> The role of data flywheels and ML in improving drug discovery success rates >> Real-world case studies from biotech collaborations >> How OpenBench evaluates druggable targets in one week Meet our guest James Yoder is the Founder and CEO of OpenBench. With a background in statistics, data science, and applied machine learning, he leads OpenBench's mission to deliver validated drug discovery hits through computational innovation and a success-driven business model. About the host Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation. Connect with our guest: Sponsor: CorrDyn, a data consultancy Connect with James Yoder on LinkedIn Connect with us: Follow the podcast for more insightful discussions on the latest in biotech and data science. Subscribe and leave a review if you enjoyed this episode! Connect with Ross Katz on LinkedIn Sponsored by… This episode is…","meta_description":"In this episode of Data in Biotech , host Ross Katz sits down with James Yoder, Founder and CEO of OpenBench, to unpack a radical new approach to early-st…","key_points":[],"chapters":[],"topics":[],"duration_seconds":3217,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/data-in-biotech-6628050/episodes/success-driven-drug-discovery-with-openbench-ceo-james-yoder/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/data-in-biotech-6628050/success-driven-drug-discovery-with-openbench-ceo-james-yoder.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}